4//SEC Filing
REINHARDT MAX 4
Accession 0001209191-22-053275
CIK 0001396814other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 4:13 PM ET
Size
5.3 KB
Accession
0001209191-22-053275
Insider Transaction Report
Form 4
REINHARDT MAX
President
Transactions
- Sale
Common Stock
2022-10-07$58.00/sh−1,380$80,040→ 31,378 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001780058
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 4:13 PM ET
- Size
- 5.3 KB